Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Hepatitis

Free Subscription 01.07.2019 1 BMC Gastroenterol 2 Clin Infect Dis 1 Eur J Gastroenterol Hepatol 2 Gastroenterology 3 Hepatology 1 Int J STD AIDS 3 J Hepatol 1 J Med Virol 3 J Viral Hepat 1 J Virol 4 PLoS One 1 Vaccine

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

BMC Gastroenterol

1. HE L, Ye X, Ma J, Li P, et al
   Antiviral therapy reduces rebleeding rate in patients with hepatitis B-related cirrhosis with acute variceal bleeding after endotherapy.
   BMC Gastroenterol. 2019;19:101.
   PubMed     Text format     Abstract available
   
   

   
   Clin Infect Dis

2. WADE AJ, Doyle JS, Gane E, Stedman C, et al
   Outcomes of treatment for hepatitis C in primary care compared to hospital-based care: a randomised controlled trial in people who inject drugs.
   Clin Infect Dis. 2019 Jun 22. pii: 5522438. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
3. KING H, Xing J, Dean HD, Holtzman D, et al
   Trends in prevalence of protective levels of hepatitis B surface antibody among adults aged 18-49 years with risk factors for hepatitis B virus infection-United States, 2003-2014.
   Clin Infect Dis. 2019 Jun 20. pii: 5522094. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   

   
   Eur J Gastroenterol Hepatol

4. ABD-ELSALAM S, Arafa M, Elkadeem M, Elfert A, et al
   Randomized-controlled trial of methocarbamol as a novel treatment for muscle cramps in cirrhotic patients.
   Eur J Gastroenterol Hepatol. 2019;31:499-502.
   PubMed     Text format     Abstract available
   
   

   
   Gastroenterology

5. COLPITTS CC, Baumert TF
   SMAD about HCV cell entry and pathogenesis of liver disease.
   Gastroenterology. 2016 Nov 23. pii: S0016-5085(16)35398.
   PubMed     Text format    
   
   
6. HOWELL J, Thompson AJ
   Hepatocellular Carcinoma After Sustained Virologic Response: Leave No One Behind.
   Gastroenterology. 2017 Mar 28. pii: S0016-5085(17)30334.
   PubMed     Text format    
   
   

   
   Hepatology

7. WONG GL, Wong VW, Yuen BW, Tse YK, et al
   An aging population of chronic hepatitis B with increasing co-morbidities - a territory-wide study from 2000 to 2017.
   Hepatology. 2019 Jun 25. doi: 10.1002/hep.30833.
   PubMed     Text format     Abstract available
   
   
8. LE MH, Yeo YH, Cheung R, Henry L, et al
   Chronic hepatitis B prevalence among foreign-born and US-born adults in the United States, 1999-2016.
   Hepatology. 2019 Jun 22. doi: 10.1002/hep.30831.
   PubMed     Text format     Abstract available
   
   
9. LANG S, Duan Y, Liu J, Torralba MG, et al
   Intestinal fungal dysbiosis and systemic immune response to fungi in patients with alcoholic hepatitis.
   Hepatology. 2019 Jun 22. doi: 10.1002/hep.30832.
   PubMed     Text format     Abstract available
   
   

   
   Int J STD AIDS

10. FRADE PC, Raiol NC, da Costa LM, Pinheiro LM, et al
    Prevalence and genotyping of hepatitis B virus: a cross-sectional study conducted with female sex workers in the Marajo Archipelago, Brazil.
    Int J STD AIDS. 2019 Jun 21:956462419849252. doi: 10.1177/0956462419849252.
    PubMed     Text format    
    
    

    
    J Hepatol

11. ZHU S, Dong Y, Wang L, Liu W, et al
    Early initiation of antiviral therapy contributes to a rapid and significant loss of serum HBsAg in infantile-onset hepatitis B.
    J Hepatol. 2019 Jun 19. pii: S0168-8278(19)30356.
    PubMed     Text format     Abstract available
    
    
12. WONG T, Fung J
    Reply to "Liver transplantation using hepatitis B core positive grafts: Which is the optimal antiviral prophylaxis?"
    J Hepatol. 2019 Jun 20. pii: S0168-8278(19)30350.
    PubMed     Text format    
    
    
13. CHOLONGITAS E, Papatheodoridis GV
    Liver transplantation using hepatitis B core positive grafts: Which is the optimal antiviral prophylaxis?
    J Hepatol. 2019 Jun 21. pii: S0168-8278(19)30285.
    PubMed     Text format    
    
    

    
    J Med Virol

14. TONG S, Pan J, Tang J
    Study on the structure optimization and anti-hepatitis B virus activity of novel human La protein inhibitor HBSC11.
    J Med Virol. 2019 Jun 26. doi: 10.1002/jmv.25528.
    PubMed     Text format     Abstract available
    
    

    
    J Viral Hepat

15. VILLANI R, Monami M, Di Cosimo F, Fioravanti G, et al
    Direct-Acting antivirals for HCV treatment in older patients: a systematic review and meta-analysis.
    J Viral Hepat. 2019 Jun 27. doi: 10.1111/jvh.13169.
    PubMed     Text format     Abstract available
    
    
16. CHUNG S, Roh EY, Park B, Lee Y, et al
    GWAS identifying HLA-DPB1 gene variants associated with responsiveness to hepatitis B virus vaccination in Koreans: Independent association of HLA-DPB1*04:02 possessing rs1042169 G - rs9277355 C - rs9277356 A.
    J Viral Hepat. 2019 Jun 27. doi: 10.1111/jvh.13168.
    PubMed     Text format     Abstract available
    
    
17. PELEG N, Issachar A, Sneh-Arbib O, Cohen-Naftaly M, et al
    Liver steatosis is a major predictor of poor outcomes in chronic hepatitis C patients with sustained virologic response.
    J Viral Hepat. 2019 Jun 27. doi: 10.1111/jvh.13167.
    PubMed     Text format     Abstract available
    
    

    
    J Virol

18. PATRA T, Sasaki R, Meyer K, Ray RB, et al
    TGF-beta acts as a regulatory molecule for lipogenic pathway among hepatitis C virus genotype specific infection.
    J Virol. 2019 Jun 26. pii: JVI.00811-19. doi: 10.1128/JVI.00811.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

19. BAROCAS JA, So-Armah K, Cheng DM, Lioznov D, et al
    Zinc deficiency and advanced liver fibrosis among HIV and hepatitis C co-infected anti-retroviral naive persons with alcohol use in Russia.
    PLoS One. 2019;14:e0218852.
    PubMed     Text format     Abstract available
    
    
20. IZQUIERDO L, Mellon G, Buchaillet C, Fac C, et al
    Prevalence of hepatitis E virus and reassessment of HIV and other hepatitis virus seroprevalences among French prison inmates.
    PLoS One. 2019;14:e0218482.
    PubMed     Text format     Abstract available
    
    
21. HAERI MAZANDERANI A, Motaze NV, McCarthy K, Suchard M, et al
    Hepatitis A virus seroprevalence in South Africa - Estimates using routine laboratory data, 2005-2015.
    PLoS One. 2019;14:e0216033.
    PubMed     Text format     Abstract available
    
    
22. BREZZI M, Bertisch B, Roelens M, Moradpour D, et al
    Impact of geographic origin on access to therapy and therapy outcomes in the Swiss Hepatitis C Cohort Study.
    PLoS One. 2019;14:e0218706.
    PubMed     Text format     Abstract available
    
    

    
    Vaccine

23. SONG S, Li P, Zhang R, Chen J, et al
    Oral vaccine of recombinant Lactococcus lactis expressing the VP1 protein of duck hepatitis A virus type 3 induces mucosal and systemic immune responses.
    Vaccine. 2019 Jun 18. pii: S0264-410X(19)30787.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: